Lilly Asia Ventures

Offices: Shanghai (China), Hong Kong, Menlo Park (United States)

Stages: Seed, Series A, Series B

Markets: Biomedical/Life Sciences/BioTech (Biopharmaceuticals, Human Therapeutics, Medical Devices/MedTech, Diagnostics)